MANILA, Philippines — Researchers achieved an 86-percent response accuracy rate for a hand orthosis for stroke rehabilitation ...

Executives from Biomea Fusion (NASDAQ:BMEA) discussed the company’s lead diabetes program, icovamenib, and outlined near-term ...

The company's Biomea that is the lead program, icovamenib, is the first in the category of menin inhibitors directed to the treatment of both type 1 and type 2 diabetes that holds the potential to ...

Researchers at the University of California, Irvine, have developed a polymeric biohybrid cardiac device that harnesses the ...

Research presented by Dr Jimena Perez Sanchez at ELRIG in Cambridge has set out how chemogenetics and related gene therapy strategies may reduce chronic pain by dampening hyperactive peripheral ...

Keep sending in your questions to: [email protected] to another edition of Hello, Doctor — the TOI+ series ...

The Study Accordingly, the Center for Mindfulness and Compassion at the Cambridge Health Alliance did a proof-of-concept ...

People are buying helmets, face masks, vests and beds that emit long-wavelength light. Beneath the hype, there is some ...

Many therapists recognize dissociation but feel unsure how to treat it. When dissociation is present, standard trauma ...

For many depression patients, relief means trying all sorts of different medications. But now, more people are discovering transcranial magnetic stimulation, a therapy for the brain.

Scientists have developed a new gene therapy that quiets pain at its source in the brain—without the addictive risks of opioids. Using AI to map how pain is processed, they created a targeted “off ...